| scholarly article | Q13442814 |
| P50 | author | Ana González-Pinto | Q56995383 |
| P2093 | author name string | Iñaki Zorrilla | |
| Juan Carlos Leza | |||
| Mónica Martínez-Cengotitabengoa | |||
| Karina S MacDowell | |||
| Purificación López | |||
| Susana Alberich | |||
| Saínza García | |||
| P2860 | cites work | The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance | Q52112284 |
| The complex association between the antioxidant defense system and clinical status in early psychosis. | Q52308849 | ||
| [Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients] | Q52880030 | ||
| Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: A 12-months follow-up study | Q53587393 | ||
| Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment | Q57612798 | ||
| Total antioxidant response in patients with schizophrenia | Q80048800 | ||
| A children's global assessment scale (CGAS) | Q28271291 | ||
| Treatment of bipolar disorder | Q28290437 | ||
| Development of a Rating Scale for Primary Depressive Illness | Q29616244 | ||
| Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids | Q29616817 | ||
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| Online psycho-education to the treatment of bipolar disorder: protocol of a randomized controlled trial | Q30832791 | ||
| Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. | Q31836810 | ||
| Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. | Q33820188 | ||
| Treatment non-adherence in affective disorders. | Q34592227 | ||
| Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies | Q35856498 | ||
| BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year. | Q36377832 | ||
| Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study | Q36746449 | ||
| Psychometric properties and validation of a four-item version of the Strauss-Carpenter scale in bipolar disorder. | Q37348246 | ||
| Schizophrenia, "just the facts" 4. Clinical features and conceptualization | Q37425853 | ||
| The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. | Q37581138 | ||
| Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia | Q37598239 | ||
| Antipsychotic medication and oxidative cell stress: a systematic review. | Q37776771 | ||
| The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome. | Q38295523 | ||
| Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response | Q38381132 | ||
| Nrf2 Weaves an Elaborate Network of Neuroprotection Against Stroke. | Q38723314 | ||
| The functional interactome of GSTP: A regulatory biomolecular network at the interface with the Nrf2 adaption response to oxidative stress. | Q38753254 | ||
| The Atypical Antipsychotic Paliperidone Regulates Endogenous Antioxidant/Anti-Inflammatory Pathways in Rat Models of Acute and Chronic Restraint Stress | Q38809746 | ||
| Impact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture. | Q38842712 | ||
| Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review | Q38852539 | ||
| Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants | Q39092792 | ||
| Concurrent and predictive validity of a self-reported measure of medication adherence | Q39512844 | ||
| Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia | Q40390046 | ||
| Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone | Q40675735 | ||
| First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment | Q42479721 | ||
| The role of oxidative stress in antipsychotics induced ovarian toxicity. | Q46335167 | ||
| Mood Stabilizers, Oxidative Stress and Antioxidative Defense in Euthymia of Bipolar Disorder | Q46576751 | ||
| Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics | Q46821885 | ||
| Lithium induced oxidative damage and inflammation in the rat's heart: Protective effect of grape seed and skin extract | Q47766031 | ||
| Psychiatrists' perceptions of potential reasons for non- and partial adherence to medication: results of a survey in bipolar disorder from eight European countries | Q48637084 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antioxidant activity | Q14819235 |
| P304 | page(s) | 162 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Frontiers in Psychiatry | Q27723495 |
| P1476 | title | Association Between Medication Adherence and Oxidative Stress in Patients With First-Episode Mania | |
| P478 | volume | 10 |
Search more.